Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
- PMID: 10974056
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1
Abstract
Apolipoprotein A-I (apoA-I) and an apoA-I peptide mimetic removed seeding molecules from human low density lipoprotein (LDL) and rendered the LDL resistant to oxidation by human artery wall cells. The apoA-I-associated seeding molecules included hydroperoxyoctadecadienoic acid (HPODE) and hydroperoxyeicosatetraenoic acid (HPETE). LDL from mice genetically susceptible to fatty streak lesion formation was highly susceptible to oxidation by artery wall cells and was rendered resistant to oxidation after incubation with apoA-I in vitro. Injection of apoA-I (but not apoA-II or murine serum albumin) into mice rendered their LDL resistant to oxidation within 3 h. Infusion of apoA-I into humans rendered their LDL resistant to oxidation within 6 h. We conclude that 1) oxidation of LDL by artery wall cells requires seeding molecules that include HPODE and HPETE; 2) LDL from mice genetically susceptible to atherogenesis is more readily oxidized by artery wall cells; and 3) normal HDL and its components can remove or inhibit the activity of lipids in freshly isolated LDL that are required for oxidation by human artery wall cells.
Similar articles
-
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.J Lipid Res. 2000 Sep;41(9):1495-508. J Lipid Res. 2000. PMID: 10974057
-
ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells.Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1877-83. doi: 10.1161/01.atv.0000035700.82829.2a. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426219
-
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids.J Lipid Res. 2001 Aug;42(8):1308-17. J Lipid Res. 2001. PMID: 11483633
-
Pathogenesis of atherosclerosis.Am J Cardiol. 1995 Sep 28;76(9):18C-23C. doi: 10.1016/s0002-9149(99)80466-4. Am J Cardiol. 1995. PMID: 7572682 Review.
-
The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.Mol Nutr Food Res. 2005 Nov;49(11):1075-82. doi: 10.1002/mnfr.200500063. Mol Nutr Food Res. 2005. PMID: 16270280 Review.
Cited by
-
Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis.Arthritis Rheum. 2013 Nov;65(11):2765-72. doi: 10.1002/art.38118. Arthritis Rheum. 2013. PMID: 23917967 Free PMC article.
-
Modifying the anti-inflammatory effects of high-density lipoprotein.Curr Atheroscler Rep. 2007 Jan;9(1):57-63. doi: 10.1007/BF02693941. Curr Atheroscler Rep. 2007. PMID: 17169248 Review.
-
Anion exchange HPLC isolation of high-density lipoprotein (HDL) and on-line estimation of proinflammatory HDL.PLoS One. 2014 Mar 7;9(3):e91089. doi: 10.1371/journal.pone.0091089. eCollection 2014. PLoS One. 2014. PMID: 24609013 Free PMC article.
-
Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells.J Lipids. 2016;2016:9891316. doi: 10.1155/2016/9891316. Epub 2016 Nov 9. J Lipids. 2016. PMID: 27957343 Free PMC article.
-
A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors.Prostaglandins Other Lipid Mediat. 2007 Aug;84(1-2):24-33. doi: 10.1016/j.prostaglandins.2007.03.004. Epub 2007 Mar 14. Prostaglandins Other Lipid Mediat. 2007. PMID: 17643885 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources